BIOVET is a leading European manufacturer and marketer of medicated and nutritional feed additives, enzymes, bulk active substances and pharmaceuticals for farm animal productivity and animal health. The company offers intermediates, active ingredients and medicines for the human pharmaceuticals industry. We provide enzymes, enzyme complexes and other ingredients for the baking, brewing, juice production, alcohol production, wine-making, oil extraction, pharmaceuticals, paper, detergents, leather and textiles industries. Huvepharma has offices and subsidiaries in Bulgaria, Belgium, Poland, China, Taiwan, Thailand, USA, Russia, India, Turkey and Brazil. Huvepharma and its representatives worldwide are responsible for marketing of a wide range of products. This sales and marketing network allows Huvepharma to distribute its products and services to customers worldwide.
- Business Type:
- Industry Type:
- Agriculture - Livestock
- Market Focus:
- Globally (various continents)
Biovet Joint Stock Company is a public company listed on the Bulgarian Stock Exchange:
- Stock Exchange Listing: Bulgarian Stock Exchange - Sofia
- Stock Symbol:53b
- Biovet's stock is included in the composition of the SOFIX stock exchange index.
HUVEPHARMA Ltd. ( Bulgaria ), owns 83 percent of Biovet's shares.
Huvepharma is a fast-growing global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products. These pillars are the basis of our company name, Huvepharma: HUman and VEterinary PHARMAceuticals. We place equal emphasis on the creation and marketing of products for animals and for humans. The company also manufactures and markets enzymes for food, feed and industrial applications. Huvepharma is a privately-owned company, headquartered in Sofia, Bulgaria.
Huvepharma's manufacturing subsidiary, Biovet, is headquartered in Peshtera, Bulgaria, and it had four independent manufacturing units at four locations. Its modern fermentation plants provide a high capacity for production of major molecules including purification and downstream processing. The production subsidiary also has extensive R&D, quality assurance and packaged good facilities. Our expertise lies in the creation of a close partnership with the customer and in the emphasis we place on best addressing a customer's total requirements for pharmaceuticals and feed additives. In each of our locations, Huvepharma employs highly skilled individuals with extensive experience in the animal health industry and with knowledge of their local markets and customers.
Biovet was established in 1961, more than 50 years ago. The first manufacturing plant was dedicated to the production of just one major animal health antibiotic. Throughout the decades, Biovet has been manufacturing a range of veterinary and human products in response to the changing market demands. Today, the product portfolio includes over 80 products for animal health, human health and enzymes.
Since its founding, the company has grown significantly. We increased our workforce and expanded our production facilities several times, established a Research and Development department and built a waste water treatment facility. Over the recent years we have made significant investments in plant upgrades, equipment automation, and construction of new production areas, laboratories and warehouses. At present, the administrative and production complex extends over an area of approximately 150 000 m2.
Our company headquarters is located in the town of Peshtera, Bulgaria, 120 km southeast of the country's capital, Sofia. Peshtera is situated in a picturesque valley in the Rhodopi mountains – area of pristine natural beauty where keeping the environment clean is of top priority. Most administrative and manufacturing activities are carried out at headquarters. The R&D center is also located in Peshtera.
In addition to Peshtera, Biovet has manufacturing facilities in two other locations in Bulgaria and one in Macedonia. Biovet's second manufacturing facility in Bulgaria is in Botevgrad and it is dedicated to the manufacting of enzymes. Biovet's third manufacturing location in Bulgaria is in Razgrad. We acquired Balkanpharma – Razgrad from Actavis (Iceland) in July 2005. Biovet's fourth manufacturing location is in Shtip, Macedonia. This plant was also acquired from Actavis (Iceland).
Biovet plays a vital role in the community because we care greatly about the towns we operate in and their citizens. We employ over 1000 people and we offer special benefits to them and their families. We provide financial assistance to local county institutions and organizations and we sponsor community events. We played an important role in the creation of a gas distribution network to households in Peshtera.